Zezhong Liu

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Angiotensin Converting Enzyme

Pluripotent Stem Cells

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Zezhong Liu, Jie Zhou, Xinling Wang, Wei Xu, Zheng Teng, Hongyou Chen, Min Chen, Guangxu Zhang, Yuanzhou Wang, Jinghe Huang, Qian Wang, Shibo Jiang, Lu Lu
A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates. Proceedings of the National Academy of Sciences of the United States of America 120 (11) (2023)
Zezhong Liu, Jie Zhou, Xinling Wang, Wei Xu, Zheng Teng, Hongyou Chen, Min Chen, Guangxu Zhang, Yuanzhou Wang, Jinghe Huang, Qian Wang, Shibo Jiang, Lu Lu
A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates. Proceedings of the National Academy of Sciences of the United States of America 120 (11) (2023)
Zezhong Liu, Jie Zhou, Xinling Wang, Wei Xu, Zheng Teng, Hongyou Chen, Min Chen, Guangxu Zhang, Yuanzhou Wang, Jinghe Huang, Qian Wang, Shibo Jiang, Lu Lu
A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates. Proceedings of the National Academy of Sciences of the United States of America 120 (11) (2023)
Naru Zhang, Qianting Ji, Zezhong Liu, Kaiming Tang, Yubin Xie, Kangchen Li, Jie Zhou, Sisi Li, Haotian Shang, Zecan Shi, Tianyu Zheng, Jiawei Yao, Lu Lu, Shuo-Feng Yuan, Shibo Jiang
Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant. Viruses 14 (3) (2022)
Zezhong Liu, Wei Xu, Zhenguo Chen, Wangjun Fu, Wuqiang Zhan, Yidan Gao, Jie Zhou, Yunjiao Zhou, Jianbo Wu, Qian Wang, Xiang Zhang, Aihua Hao, Wei Wu, Qianqian Zhang, Yaming Li, Kaiyue Fan, Ruihong Chen, Qiaochu Jiang, Christian Thomas Mayer, Till Schoofs, Youhua Xie, Shibo Jiang, Yumei Wen, Zhenghong Yuan, Kang Wang, Lu Lu, Lei Sun, Qiao Wang
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope. Protein & cell (2021)